{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:18:53Z","timestamp":1787509133595,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education - Kasturba Medical College, Mangalore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Health-related quality of life (HRQoL) in people living with HIV\/AIDS (PLWHA) is shaped by a combination of HIV-related and non-HIV-related factors, including immunological and virological failure, HIV-associated comorbidities, and antiretroviral therapy (ART)-induced toxicity. Although HRQoL tends to improve during the first year of combination ART (cART), especially among those with advanced HIV, disparities persist. This cross-sectional analytical study assessed HRQoL in 321 PLWHA, of whom 310 were included in the final analysis. HRQoL was evaluated using the EQ-5D-5\u00a0L index. Of the participants, 121 (37.7%) had a high EQ-5D-5\u00a0L index value of 1, whereas 181 (58.9%) had an index value of less than 1. A statistically significant positive correlation was found between the EQ-5D-5\u00a0L index and the recent CD4-T cell count (rs\u2009=\u20090.162,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.004). Gender-based analysis showed males (0.85\u2009\u00b1\u20090.15) had significantly higher HRQoL scores compared to females (0.77\u2009\u00b1\u20090.16). Furthermore, delayed switching to second-line regimens was associated with suboptimal recovery in HRQoL. These findings highlight the importance of timely clinical decisions in switching the ART to a more potent regimen especially in resource poor settings.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-28209-w","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T13:44:50Z","timestamp":1764423890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and quality of life consequences of regimen switching delays in HIV management: a stratified cohort analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Basavaraj","family":"Poojar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Natraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Vijayalakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-333X","authenticated-orcid":false,"given":"Satish","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"28209_CR1","unstructured":"World Health Organization. Data on the HIV\/AIDS response. Global Health Observatory [Internet]. Mar [cited 2025 Mar 25].https:\/\/www.who.int\/data\/gho\/data\/themes\/hiv-aids\/data-on-the-hiv-aids-response (2025)."},{"issue":"1","key":"28209_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09540121.2014.946386","volume":"27","author":"AM Bengtson","year":"2015","unstructured":"Bengtson, A. M. et al. Improvements in depression and changes in quality of life among HIV-infected adults. AIDS Care. 27 (1), 47\u201353 (2015).","journal-title":"AIDS Care"},{"issue":"5","key":"28209_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/QAD.0000000000001738","volume":"32","author":"TS Torres","year":"2018","unstructured":"Torres, T. S. et al. Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women. AIDS 32 (5), 583\u2013593 (2018).","journal-title":"AIDS"},{"key":"28209_CR4","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1590\/S1807-59322009000900007","volume":"64","author":"LN Campos","year":"2009","unstructured":"Campos, L. N., C\u00e9sar, C. C. & Guimar\u00e3es, M. D. C. Quality of life among HIV-infected patients in Brazil after initiation of treatment. Clinics 64, 867\u2013875 (2009).","journal-title":"Clinics"},{"key":"28209_CR5","unstructured":"World Health Organisation. WHOQOL: Measuring Quality of Life. Geneva: World Health Organisation. [cited 2025 Jan 28]. https:\/\/www.who.int\/healthinfo\/survey\/whoqol-qualityoflife\/en\/ (2020)."},{"issue":"1","key":"28209_CR6","doi-asserted-by":"publisher","first-page":"e25233","DOI":"10.1002\/jia2.25233","volume":"22","author":"JL Castilho","year":"2019","unstructured":"Castilho, J. L. et al. Trends and predictors of non-communicable disease Multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil. J. Int. AIDS Soc. 22 (1), e25233 (2019).","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"28209_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M14-0293","volume":"161","author":"KR Mollan","year":"2014","unstructured":"Mollan, K. R. et al. Association between Efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Ann. Intern. Med. 161 (1), 1\u20130 (2014).","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"28209_CR8","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2352-3018(14)70018-9","volume":"1","author":"A Miners","year":"2014","unstructured":"Miners, A. et al. Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population. Lancet HIV. 1 (1), e32\u201340 (2014).","journal-title":"Lancet HIV"},{"key":"28209_CR9","doi-asserted-by":"crossref","unstructured":"Bimal Charles, B. C. et al. Association between stigma, depression and quality of life of people living with HIV\/AIDS (PLHA) in South India\u2013a community based cross sectional study. BMC Public. Health 12(1). (2012).","DOI":"10.1186\/1471-2458-12-463"},{"key":"28209_CR10","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1007\/s10461-018-2157-7","volume":"22","author":"ML Ekstrand","year":"2018","unstructured":"Ekstrand, M. L. et al. The role of HIV stigma in ART adherence and quality of life among rural women living with HIV in India. AIDS Behav. 22, 3859\u20133868 (2018).","journal-title":"AIDS Behav."},{"issue":"1","key":"28209_CR11","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/S2352-3018(14)70003-7","volume":"1","author":"A Pozniak","year":"2014","unstructured":"Pozniak, A. Quality of life in chronic HIV infection. Lancet HIV. 1 (1), e6\u20137 (2014).","journal-title":"Lancet HIV"},{"key":"28209_CR12","unstructured":"World Health Organization. Update of recommendations on first- and second-line antiretroviral regimens [Internet]. Geneva, Switzerland: World Health Organization. May 7 [cited 2025 Jan 28]. https:\/\/www.who.int (2019)."},{"issue":"6","key":"28209_CR13","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.4103\/jfmpc.jfmpc_288_19","volume":"8","author":"RT Wani","year":"2019","unstructured":"Wani, R. T. Socioeconomic status scales\u2014modified kuppuswamy and Udai pareekh\u2019s scale updated for 2019. J. Family Med. Prim. Care. 8 (6), 1846\u20131849 (2019).","journal-title":"J. Family Med. Prim. Care"},{"issue":"5","key":"28209_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ageing\/afl041","volume":"35","author":"DB Rolfson","year":"2006","unstructured":"Rolfson, D. B., Majumdar, S. R., Tsuyuki, R. T., Tahir, A. & Rockwood, K. Validity and reliability of the Edmonton frail scale. Age Ageing. 35 (5), 526\u2013529 (2006).","journal-title":"Age Ageing"},{"key":"28209_CR15","unstructured":"Van Reenen, M. et al. EQ-5D-3L User Guide. EuroQol research foundation (2018)."},{"issue":"3","key":"28209_CR16","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s11136-013-0537-z","volume":"23","author":"Y Feng","year":"2014","unstructured":"Feng, Y., Parkin, D. & Devlin, N. J. Assessing the performance of the EQ-VAS in the NHS proms programme. Qual. Life Res. 23 (3), 977\u2013989. https:\/\/doi.org\/10.1007\/s11136-013-0537-z (2014).","journal-title":"Qual. Life Res."},{"issue":"5","key":"28209_CR17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jval.2012.02.008","volume":"15","author":"B Van Hout","year":"2012","unstructured":"Van Hout, B. et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health. 15 (5), 708\u2013715 (2012).","journal-title":"Value Health"},{"key":"28209_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bjid.2019.06.005","volume":"23","author":"BS Dutra","year":"2019","unstructured":"Dutra, B. S. et al. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study. Brazilian J. Infect. Dis. 23, 211\u2013217 (2019).","journal-title":"Brazilian J. Infect. Dis."},{"key":"28209_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-016-0640-4","volume":"14","author":"JV Lazarus","year":"2016","unstructured":"Lazarus, J. V. et al. Beyond viral suppression of HIV\u2013the new quality of life frontier. BMC Med. 14, 1\u20135 (2016).","journal-title":"BMC Med."},{"issue":"14","key":"28209_CR20","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1097\/QAD.0b013e32832e05b2","volume":"23","author":"ART-LINC of IeDEA Study Group","year":"2009","unstructured":"ART-LINC of IeDEA Study Group. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. AIDS 23 (14), 1867\u20131874 (2009).","journal-title":"AIDS"},{"key":"28209_CR21","unstructured":"National, A. I. D. S. C. & Organisation NACO National Technical Guidelines on ART. Ministry of Health, Government of India; [cited 2025 Jan 28].https:\/\/naco.gov.in\/sites\/default\/files\/NACO%20-%20National%20Technical%20Guidelines%20on%20ART_October%202018%20%281%29.pdf (2018)."},{"key":"28209_CR22","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization  https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572730\/ (2021)."},{"key":"28209_CR23","unstructured":"World Health Organization. Potential safety issue affecting women living with HIV using dolutegravir at the time of conception [Internet]. Geneva: World Health Organization. http:\/\/www.who.int\/medicines\/publications\/drugalerts\/Statement_on_DTG_18May_2018final.pdf?ua=1 (2018)."},{"issue":"1","key":"28209_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ijp.IJP_241_19","volume":"52","author":"MN Chowta","year":"2020","unstructured":"Chowta, M. N., Kumbla, R. A., D\u2019Souza, G., Rai, A. & Gopalakrishna, H. N. Changing patterns of adverse drug reactions in HIV patients receiving antiretroviral therapy. Indian J. Pharmacol. 52 (1), 35\u201340. https:\/\/doi.org\/10.4103\/ijp.IJP_241_19 (2020).","journal-title":"Indian J. Pharmacol."},{"issue":"4","key":"28209_CR25","doi-asserted-by":"publisher","first-page":"FC01","DOI":"10.7860\/JCDR\/2018\/34819.11396","volume":"12","author":"A Bandyopadhyay","year":"2018","unstructured":"Bandyopadhyay, A. et al. Evaluation of adverse drug reactions in HIV-positive patients on antiretroviral therapy in a tertiary care hospital in India. J. Clin. Diagn. Res. 12 (4), FC01\u2013FC04. https:\/\/doi.org\/10.7860\/JCDR\/2018\/34819.11396 (2018).","journal-title":"J. Clin. Diagn. Res."},{"issue":"6","key":"28209_CR26","doi-asserted-by":"publisher","first-page":"e0232962","DOI":"10.1371\/journal.pone.0232962","volume":"15","author":"TL Dadi","year":"2020","unstructured":"Dadi, T. L., Feyissa, G. T., Gebreyesus, S. H. & Setegn, T. Viral load suppression and associated factors among HIV patients on antiretroviral therapy in ethiopia: a systematic review and meta-analysis. PLoS One. 15 (6), e0232962. https:\/\/doi.org\/10.1371\/journal.pone.0232962 (2020).","journal-title":"PLoS One"},{"issue":"3","key":"28209_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1056\/NEJMoa1311274","volume":"371","author":"NI Paton","year":"2014","unstructured":"Paton, N. I. et al. Assessment of second-line antiretroviral regimens for HIV therapy in Africa. N. Engl. J. Med. 371 (3), 234\u2013247 (2014).","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"28209_CR28","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jana.2017.03.004","volume":"28","author":"AM Nyamathi","year":"2017","unstructured":"Nyamathi, A. M. et al. Quality of life among women living with HIV in rural India. J. Assoc. Nurses AIDS Care. 28 (4), 575\u2013586 (2017).","journal-title":"J. Assoc. Nurses AIDS Care"},{"issue":"8","key":"28209_CR29","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1080\/09540121.2018.1427207","volume":"30","author":"TS Torres","year":"2018","unstructured":"Torres, T. S. et al. Quality of life among HIV-infected individuals failing first-line antiretroviral therapy in resource-limited settings. AIDS Care. 30 (8), 954\u2013962 (2018).","journal-title":"AIDS Care"},{"key":"28209_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s41999-018-0143-2","volume":"10","author":"TD Brothers","year":"2019","unstructured":"Brothers, T. D. & Rockwood, K. Frailty: a new vulnerability indicator in people aging with HIV. Eur. Geriatr. Med. 10, 219\u2013226 (2019).","journal-title":"Eur. Geriatr. Med."},{"issue":"3","key":"28209_CR31","first-page":"707","volume":"33","author":"SM McCluskey","year":"2019","unstructured":"McCluskey, S. M., Siedner, M. J. & Marconi, V. C. Management of virologic failure and HIV drug resistance. Infect. Disease Clin. 33 (3), 707\u2013742 (2019).","journal-title":"Infect. Disease Clin."},{"issue":"17","key":"28209_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMp1710608","volume":"377","author":"C Beyrer","year":"2017","unstructured":"Beyrer, C. & Pozniak, A. HIV drug resistance\u2014an emerging threat to epidemic control. N. Engl. J. Med. 377 (17), 1605\u20131607 (2017).","journal-title":"N. Engl. J. Med."},{"key":"28209_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s10461-008-9434-9","volume":"13","author":"PS Chandra","year":"2009","unstructured":"Chandra, P. S., Satyanarayana, V. A., Satishchandra, P., Satish, K. S. & Kumar, M. Do men and women with HIV differ in their quality of life? A study from South India. AIDS Behav. 13, 110\u2013117 (2009).","journal-title":"AIDS Behav."},{"issue":"5","key":"28209_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/09540121.2018.1563281","volume":"31","author":"DR Garfin","year":"2019","unstructured":"Garfin, D. R. et al. Depression, social support, and stigma as predictors of quality of life over time: results from an Asha-based HIV\/AIDS intervention in India. AIDS Care. 31 (5), 563\u2013571 (2019).","journal-title":"AIDS Care"},{"key":"28209_CR35","doi-asserted-by":"crossref","unstructured":"Ezeamama, A. E. et al. Depressive and anxiety symptoms predict sustained quality of life deficits in HIV-positive Ugandan adults despite antiretroviral therapy: a prospective cohort study. Medicine (2016).","DOI":"10.1097\/MD.0000000000002525"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28209-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28209-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:40:04Z","timestamp":1777131604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28209-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28209"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28209-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45727"}}